|
NANJING, China, Sept. 14, 2024 /PRNewswire/ - - On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096. HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation by the U. S. Food and Drug ...
Adnkronos
-
14-9-2024
|
|